Amneal Pharmaceuticals, Inc. (AMRX) key performance indicators and operating metrics (3 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adjusted Diluted Earnings per Share | 0.17 USD_per_share | FY2025-Q3 |
| Adjusted Earnings Before Interest Taxes Depreciation and Amortization | 160M | FY2025-Q3 |
| Net Revenue Guidance | 785M | FY2025-Q3 |
Back to AMRX overview · AMRX earnings · AMRX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.